{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:31:22Z","timestamp":1765546282413,"version":"3.37.3"},"reference-count":24,"publisher":"Japan Epidemiological Association","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Epidemiology"],"published-print":{"date-parts":[[2018]]},"DOI":"10.2188\/jea.je20170008","type":"journal-article","created":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T18:19:46Z","timestamp":1509733186000},"page":"75-80","source":"Crossref","is-referenced-by-count":7,"title":["Improvement in 5-Year Relative Survival in Cancer of the Corpus Uteri From 1993\u20132000 to 2001\u20132006 in Japan"],"prefix":"10.2188","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7312-0615","authenticated-orcid":false,"given":"Shusaku","family":"Inoue","sequence":"first","affiliation":[{"name":"Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute"},{"name":"Department of Gynecology and Obstetrics, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2569-0127","authenticated-orcid":false,"given":"Satoyo","family":"Hosono","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute"},{"name":"Department of Epidemiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Oze","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Nishino","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, Kanazawa Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Hattori","sequence":"additional","affiliation":[{"name":"Department of Cancer Therapy Center, Fukui Prefectural Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Cancer Information Services and Surveillance Division, Center for Cancer Control and Information Services, National Cancer Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Miyashiro","sequence":"additional","affiliation":[{"name":"Cancer Control Center, Osaka International Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomio","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Cancer Control Center, Osaka International Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Aichi Cancer Center Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1761-6314","authenticated-orcid":false,"given":"Keitaro","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute"},{"name":"Department of Epidemiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoko","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Gynecology and Obstetrics, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute"},{"name":"Osaka Prefectural Health Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Ito","sequence":"additional","affiliation":[{"name":"Cancer Control Center, Osaka International Cancer Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the J-CANSIS Research Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"991","reference":[{"key":"1","unstructured":"1. SEER Cancer Statistics Review, 1975\u20132012, National Cancer Institute. http:\/\/seer.cancer.gov\/csr\/1975_2012\/. Accessed 16.08.20."},{"key":"2","unstructured":"2. Sant M, Chirlaque Lopez MD; EUROCARE-5 Working Group. Survival of women with cancers of breast and genital organs in Europe 1999\u20132007: results of the EUROCARE-5 study. <i>Eur J Cancer<\/i>. 2015."},{"key":"3","unstructured":"3. Nishimoto H, Matsuda T, Shibata A, Matsuda A. <i>Monitoring of Cancer Incidence in Japan - Survival 2003\u20132005 Report<\/i>. Tokyo, Japan: Center for Cancer Control and Information Services National Cancer Center; 2013."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Chen T, Jansen L; GEKID Cancer Survival Working Group. Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. <i>BMC Cancer<\/i>. 2012;12:128.","DOI":"10.1186\/1471-2407-12-128"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ferlay J, Soerjomataram I, Dikshit R, et\u00a0al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. <i>Int J Cancer<\/i>. 2015;136:E359\u2013E386.","DOI":"10.1002\/ijc.29210"},{"key":"6","unstructured":"6. Cancer Information Service National Cancer Center, Japan. Cancer Registry and Statistics. http:\/\/ganjoho.jp\/reg_stat\/statistics\/dl\/index.html. Accessed 16.08.20."},{"key":"7","unstructured":"7. Ministry of Health Labour and Welfare. Vital Statistics Japan. http:\/\/ganjoho.jp\/reg_stat\/statistics\/dl\/index.html. Accessed 16.08.20."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. <i>Lancet<\/i>. 2005;366:491\u2013505.","DOI":"10.1016\/S0140-6736(05)67063-8"},{"key":"9","unstructured":"9. Japan Society of Gynecologic Oncology. <i>Treatment Guidelines for Uterine Body Cancer<\/i>. 2006 ed. Tokyo, Japan: Kanehara &amp; Co., Ltd; 2006."},{"key":"10","unstructured":"10. The 41st annual report of the committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology. <i>Acta Obstet Gynaecol Jpn<\/i>. 2008;60:1898."},{"key":"11","unstructured":"11. The 54th annual report of the committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology. <i>Acta Obstet Gynaecol Jpn<\/i>. 2014;66:1064."},{"key":"12","unstructured":"12. Nakamura T, Onishi Y, Yamamoto F, Kouno S, Maeda Y, Hatae M. [Evaluation of paclitaxel and carboplatin in patients with endometrial cancer]. <i>Gan To Kagaku Ryoho<\/i>. 2000;27:257\u2013262 (in Japanese)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Watanabe Y, Kitagawa R; Disease Committee of Uterine Endometrial Cancer, Japanese Gynecologic Oncology Group. Practice pattern for postoperative management of endometrial cancer in Japan: a survey of the Japanese Gynecologic Oncology Group. <i>Gynecol Oncol<\/i>. 2009;115:456\u2013459.","DOI":"10.1016\/j.ygyno.2009.08.016"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Homesley HD. Present status and future direction of clinical trials in advanced endometrial carcinoma. <i>J Gynecol Oncol<\/i>. 2008;19:157\u2013161.","DOI":"10.3802\/jgo.2008.19.3.157"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ito Y, Miyashiro I; J-CANSIS Research Group. Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data. <i>Cancer Sci<\/i>. 2014;105:1480\u20131486.","DOI":"10.1111\/cas.12525"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Est\u00e8ve J, Benhamou E, Croasdale M, Raymond L. Relative survival and the estimation of net survival: elements for further discussion. <i>Stat Med<\/i>. 1990;9:529\u2013538.","DOI":"10.1002\/sim.4780090506"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. <i>Stat Med<\/i>. 2004;23:51\u201364.","DOI":"10.1002\/sim.1597"},{"key":"18","unstructured":"18. StataCorp. Stata Statistical Software: Release 13. 13.1 ed. College station, TX: StataCorp LP; 2013."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Klint A, Tryggvad\u00f3ttir L, Bray F, et\u00a0al. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964\u20132003 followed up to the end of 2006. <i>Acta Oncol<\/i>. 2010;49:632\u2013643.","DOI":"10.3109\/02841861003691945"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Boll D, Karim-Kos HE, Verhoeven RH, et\u00a0al. Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in The Netherlands: a population based study. <i>Eur J Obstet Gynecol Reprod Biol<\/i>. 2013;166:209\u2013214.","DOI":"10.1016\/j.ejogrb.2012.10.028"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Brenner H, Gondos A, Arndt V. Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. <i>J Clin Oncol<\/i>. 2007;25:3274\u20133280.","DOI":"10.1200\/JCO.2007.11.3431"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Toyoshima M, Akahira J, Matsunaga G, et\u00a0al. Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus. <i>Gynecol Oncol<\/i>. 2004;94:774\u2013778.","DOI":"10.1016\/j.ygyno.2004.05.048"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Dietrich CS 3rd, Modesitt SC, DePriest PD, et\u00a0al. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC). <i>Gynecol Oncol<\/i>. 2005;99:557\u2013563.","DOI":"10.1016\/j.ygyno.2005.07.104"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zanotti KM, Belinson JL, Kennedy AW, Webster KD, Markman M. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma. <i>Gynecol Oncol<\/i>. 1999;74:272\u2013277.","DOI":"10.1006\/gyno.1999.5444"}],"container-title":["Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/28\/2\/28_JE20170008\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T11:38:00Z","timestamp":1570275480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jea\/28\/2\/28_JE20170008\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2188\/jea.je20170008","relation":{},"ISSN":["0917-5040","1349-9092"],"issn-type":[{"type":"print","value":"0917-5040"},{"type":"electronic","value":"1349-9092"}],"subject":[],"published":{"date-parts":[[2018]]}}}